Structure of Teniposide
CAS No.: 29767-20-2
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Teniposide, a derivative of podophyllotoxin, can interact with DNA topoisomerase II and is used in cancer medicine.
Synonyms: VM26; NSC 122819; HSDB 6546
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 29767-20-2 |
Formula : | C32H32O13S |
M.W : | 656.65 |
SMILES Code : | O=C1OC[C@]2([H])[C@H](O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO4)O3)O[C@@H]4C5=CC=CS5)O)O)C6=C(C=C7OCOC7=C6)[C@@H](C8=CC(OC)=C(O)C(OC)=C8)[C@]21[H] |
Synonyms : |
VM26; NSC 122819; HSDB 6546
|
MDL No. : | MFCD00866516 |
InChI Key : | NRUKOCRGYNPUPR-QBPJDGROSA-N |
Pubchem ID : | 452548 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H351-H361 |
Precautionary Statements: | P280-P305+P351+P338 |
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
MDA-MB-231 | 500 nM | 24 hours | To assess the effect of Teniposide on cell viability, results showed minimal impact on cell viability at low concentrations. | PMC11079014 |
Glioblastoma stem-like cells (GSCs) | 0.5 µM | 24 hours | To evaluate the cytotoxic effect of Teniposide on GSCs under normoxic and hypoxic conditions. Results showed that Teniposide decreased GSC viability under normoxia but no changes were observed under hypoxia, indicating hypoxia enhances chemoresistance of GSCs to Teniposide. | PMC9409164 |
MDA-MB-231-1833 | 500 nM | 5 days | To evaluate the effect of Teniposide on 3D growth morphology, results showed Teniposide significantly reduced invasive growth morphology. | PMC11079014 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
BALB/c mice | CT26 tumor model | Intraperitoneal injection | 10 mg/kg | Once on day 6 and once on day 7 | To evaluate the inhibitory effect of Teniposide on tumor growth and its impact on immune cell infiltration in the tumor microenvironment. Results showed that Teniposide significantly inhibited tumor growth and increased the number and activity of tumor-infiltrating CD8+ T cells. | PMC6819145 |
C57BL/6J mice | Hepa1-6 liver orthotopic tumor model | Intraperitoneal injection | 10 mg/kg | Twice, interval not specified | Evaluate the effect of HBO combined with teniposide treatment on the efficacy of PD-1 antibody. Results showed that HBO significantly enhanced teniposide-induced cGAS-STING-dependent tumor type I interferon and NF-κB signaling, both of which contributed to the activation of dendritic cells and subsequent cytotoxic T cells. | PMC9413187 |
Nude mice | Breast cancer lung metastasis model | Tail vein injection | 500 nM | Single injection, observed for 21 days | To assess the effect of Teniposide on breast cancer lung metastasis, results showed Teniposide significantly reduced the formation of lung metastatic colonies. | PMC11079014 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00198991 | Adult Acute Lymphocytic Leukem... More >>ia Less << | Phase 4 | Unknown | - | Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD ++49(0)69 6301 5194 hoelzer@em.uni-frankfurt.de Contact: Nicola Goekbuget, MD ++49(0)69 6301 6365 goekbuget@em.uni-frankfurt.de Principal Investigator: Dieter Hoelzer, MD,PhD Sub-Investigator: Nicola Goekbuget, MD Less << |
NCT02086942 | Multiple Myeloma | Phase 2 | Recruiting | August 2017 | China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: zhai yo ping, doctor 13951947646 ypzhai@medmail.com.cn Less << |
NCT00199004 | Adult Acute Lymphocytic Leukem... More >>ia Less << | Phase 4 | Completed | - | Germany ... More >> University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany, 60590 Less << |
NCT00199056 | Adult Acute Lymphocytic Leukem... More >>ia Less << | Phase 4 | Completed | - | Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less << |
NCT00199095 | Adult Acute Lymphocytic Leukem... More >>ia Less << | Phase 4 | Completed | - | Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less << |
NCT00002531 | Leukemia | Phase 2 | Unknown | - | Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less << |
NCT02645864 | Esophageal Squamous Cell Carci... More >>noma Less << | Phase 1 | Recruiting | December 2017 | China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Xiaodong Zhang 86-10-88196961 zxd0829@hotmail.com Principal Investigator: Xiaodong Zhang Less << |
NCT00187083 | Acute Lymphoblastic Leukemia | Phase 3 | Completed | - | United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
NCT00343369 | Leukemia | Not Applicable | Unknown | - | Germany ... More >> Evangelisches Krankenhauus Bielfeld Recruiting Biefeld, Germany, 33617 Contact: N. Jorch, MD 49-52-177-278-050 Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Arnulf Pekrun, MD, PhD 49-421-497-3656 arnulf.pekrun@klinikum-bremen-mitte.de Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person 49-211-311-7990 Universitats - Kinderklinik Recruiting Greiswald, Germany, 17487 Contact: James F. Beck, MD 49-383-486-6325 beck@uni-greifswald.de University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub 49-404-2803-2580 Kreskrankenhaus Kinderabteilung Recruiting Heide, Germany, 25746 Contact: Streitberger 49-481-785-911 Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Wenzel Nuernberger, MD, PhD 49-6781-66-1582 wnuernberger@bmt-center-io.com Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: P. Thomas 49-2151-322-375 Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Dieter Koerholz, MD 49-341-9726-246 koerd@medizin.uni-leipzig.de Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: P. Gutjahr, MD 49-6131-17-2112 Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Recruiting Moenchengladbach, Germany, D-41066 Contact: Wolfgang Mueller, MD 49-2161-668-2481 Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Arndt Borkhardt 49-89-5160-4498 Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Papucek 49-89-6210-2710 Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Ove Peters 49-941-369-5404 Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Gerhard Beron, MD 49-611-43-2564 Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: B. Dohrn, MD 49-202-896-3823 bdohrn@wuppertal.helios-klinikum.de Less << |
NCT00199069 | Adult Acute Lymphocytic Leukem... More >>ia Less << | Phase 4 | Completed | - | Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less << |
NCT02788201 | Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Less << |
NCT01290120 | Burkitt Lymphoma ... More >> B-ALL Less << | Phase 2 | Completed | - | Italy ... More >> Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy Divisione Ematologia Spedali Civili Brescia, BS, Italy, 25123 Ematologia - AOU Careggi Firenze, FI, Italy Ematologia e TMO - Ospedale San Raffaele Milano, MI, Italy Ematologia - TMO - Ospedale San Gerardo Monza, MI, Italy Ematologia Ospedale San Bortolo Vicenza, VI, Italy, 36100 USC Ematologia Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Less << |
NCT02290132 | - | Unknown | July 2017 | China, Shanghai ... More >> Shanghai First People's HOSPITAL Recruiting Shanghai, Shanghai, China, 200127 Contact: YANG JUN, master 13564880726 yangjuan74@hotmail.com Contact: wang chun, doctor 13386259777 wangchun2@medmail.com.cn Less << | |
NCT00004231 | Lymphoma | Phase 2 | Completed | - | United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less << |
NCT01430013 | T Cell Lymphoma | Phase 2 | Unknown | December 2015 | China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 Less << |
NCT00853008 | Acute Lymphoblastic Leukemia | Phase 4 | Active, not recruiting | January 2019 | Spain ... More >> Hospital General Alicante, Spain Hospital Germans Trias i Pujol Badalona, Spain Clínica Teknon Barcelona, Spain Hospital Clínic i Provincial Barcelona, Spain Hospital de Sant Pau Barcelona, Spain Hospital Duran y Reynals Barcelona, Spain Hospital Vall d'Hebrón Barcelona, Spain Hospital General Castellón, Spain Hospital San Pedro de Alcántara Cáceres, Spain Hospital Puerta del Mar Cádiz, Spain Hospital Josep Trueta Girona, Spain Hospital Universitario Guadalajara, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Xeral Lugo, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico Universitario Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Carlos Haya Málaga, Spain Hospital Virgen de la Victoria Málaga, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llàtzer Palma de Mallorca, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital Clínico Universitario Salamanca, Spain Hospital Marqués de Valdecilla Santander, Spain Hospital Xeral Santiago, Spain Hospital Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Mútua de Terrassa Terrassa, Spain Hospital Clínico Universitario Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital General Valencia, Spain Hospital La Fe Valencia, Spain Hospital Clínico Valladolid, Spain Hospital Virgen de la Concha Zamora, Spain Hospital Lozano Blesa Zaragoza, Spain Less << |
NCT02028650 | - | Completed | - | China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 Less << | |
NCT00696735 | Follicular Lymphoma | Phase 3 | Completed | - | France ... More >> Emmanuel GYAN Tours, France, 37000 Philippe COLOMBAT Tours, France, 37000 Less << |
NCT00184041 | Acute Lymphoblastic Leukemia | Phase 2 | Completed | - | United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90032 Less << |
NCT01700946 | Recurrent B-Cell Childhood Acu... More >>te Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma Less << | Phase 2 | Recruiting | October 2021 | United States, California ... More >> Rady Children's Hospital and Health Center Completed San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sima Jeha, MD 866-278-5833 referralinfo@stjude.org Principal Investigator: Sima Jeha, MD United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD 682-885-4007 Principal Investigator: Kenneth M. Heym, MD Less << |
NCT00186875 | Acute Lymphoblastic Leukemia ... More >> Lymphoma, Lymphoblastic Less << | Phase 2 | Completed | - | United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less << |
NCT00186875 | - | Completed | - | - | |
NCT01960192 | Primary CNS Lymphoma (PCNSL) | Phase 4 | Recruiting | June 2020 | China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr 13838565629 mingzhi_zhang@126.com Less << |
NCT00004916 | Lymphoma | Phase 1 Phase 2 | Completed | - | United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less << |
NCT06048107 | HLH | RECRUITING | 2025-09-30 | Zhao Wang, Beijing, 100050, Ch... More >>ina, China Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.52mL 0.30mL 0.15mL |
7.61mL 1.52mL 0.76mL |
15.23mL 3.05mL 1.52mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|